TransMedics

Forecast & Rating13 analysts currently cover TransMedics, with about 61.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $97.30, about 2.7% upside from the current price of $94.77. Price targets range from $65.00 to $125.00 — a wide spread, showing clear disagreement over just how much TransMedics can rise. Historically, about 94.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study TransMedics closely still see room for the stock to rise. Data as of Aug 21, 2026; for reference only and not investment advice.